Thus, targeting DPP8/9 is considered an effective therapeutic approach to, for example, sensitize cells for cancer therapies (Bolgi et al, 2022; Benramdane et al, 2023; Bettecken et al, 2023). The gene discussed is DPP8; the disease is cancer.